Evotec is industrializing the next generation of immunotherapy through immune-shielded, iPSC-derived CAR macrophages (CAR iMACs). By integrating our proprietary iPSC platform with deep fibrosis expertise and end-to-end GMP manufacturing, we bridge the gap between complex science and scalable clinical solutions.
Discover how our integrated capabilities are accelerating the development of CAR iMACs.
